The new NIH Transformative R01 (T-R01) program, announced in September 2008, will specifically fund high-risk research in areas that are in need of radical change and progress such as pharmacogenomics, understanding and facilitating behavioral changes for disease intervention, mitochondrial variation, and dysfunction and chronic pain management. The applications for the 5-year grants are due by 29 January 2009. The grant proposals, which are unique from traditional R01 grading systems, will be evaluated by a distinctive review process being piloted by the NIH Center for Scientific Review (CSR). This new research support and review program aims to stimulate scientific creativity and unique approaches, which will hopefully lead to high-impact discoveries and breakthroughs. Further information on this program can be found online at: http://nihroadmap.nih.gov/T-R01
NIH Transformative R01 grant deadline approaches
NIH Transformative R01 grant deadline approaches. Dis Model Mech 21 November 2008; 1 (4-5): 195. doi: https://doi.org/10.1242/dmm.001800
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists